Central Nervous System Agents in Medicinal Chemistry
Title: Editorial
Volume: 11 Issue: 1
Author(s): Maria L Lopez-Rodriguez
Affiliation:
Export Options
About this article
Cite this article as:
L Lopez-Rodriguez Maria, Editorial, Central Nervous System Agents in Medicinal Chemistry 2011; 11 (1) . https://dx.doi.org/10.2174/187152411794961059
DOI https://dx.doi.org/10.2174/187152411794961059 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
14
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Epidemiology, Aetiology and Management of Major Depression with Comorbid Alcohol Use Disorder-A Review of the Literature
Current Psychiatry Reviews Neurodevelopment and Mood Stabilizers
Current Molecular Medicine Single-chain Fv Antibodies for Targeting Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Diagnosis and Treatment of Cyclothymia: The “Primacy” of Temperament
Current Neuropharmacology Editorial [Hot Topic: Novel Therapeutic Strategies in Neural Diseases Uncover Unexpected Disease Connections: From Neurodegeneration and Addiction to Pain and Depression (Guest Editor: Gonzalo Herradon)]
Current Pharmaceutical Design Anticancer and Antibacterial Activity of Hyperforin and Its Derivatives
Anti-Cancer Agents in Medicinal Chemistry Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy
Current Neuropharmacology Autoimmune Diseases and Atherosclerosis: The Inflammatory Connection
Current Immunology Reviews (Discontinued) Detecting Non-cognitive Features of Prodromal Neurodegenerative Diseases
Current Aging Science Screening and Partial Purification of Cholinesterase Inhibitor from Microalgae
Current Enzyme Inhibition The Effect of Relaxation Technique (Jacobsen and Benson) on Depression, Anxiety, and Stress in Patients with Multiple Sclerosis
Current Psychiatry Research and Reviews A Hypothesis for the Relationship between Depression and Cancer: Role of Ca2+/cAMP Signalling
Anti-Cancer Agents in Medicinal Chemistry Oxidative Stress in the ICU
Current Nutrition & Food Science Ruthenium Complexes as Anticancer Agents
Current Medicinal Chemistry Editorial:Cannabis: Neurological Correlates in Abuse and Medical Use
CNS & Neurological Disorders - Drug Targets Royal Jelly Acid, 10-Hydroxy-trans-2-Decenoic Acid, as a Modulator of the Innate Immune Responses
Endocrine, Metabolic & Immune Disorders - Drug Targets Solving the Blood-Brain Barrier Challenge for the Effective Treatment of HIV Replication in the Central Nervous System
Current Pharmaceutical Design Brain and Gut CRF Signaling: Biological Actions and Role in the Gastrointestinal Tract
Current Molecular Pharmacology Role of Nanomedicines in Delivery of Anti-Acetylcholinesterase Compounds to the Brain in Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: Paracrine Mechanisms, Signaling and Epigenetics in Repairing Damaged Tissue]
Recent Patents on Regenerative Medicine